Today’s Research Reports on Canopy Growth Corporation, Spectral Medical Inc., Knight Therapeutics Inc. and Sernova Corp.
NEW YORK, NY / ACCESSWIRE / December 4, 2017 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.
RDI has Initiated Coverage Today on:
Canopy Growth Corporation
https://rdinvesting.com/news/?ticker=WEED.TO
Spectral Medical Inc.
https://rdinvesting.com/news/?ticker=EDT.TO
Knight Therapeutics Inc.
https://rdinvesting.com/news/?ticker=GUD.TO
Sernova Corp.
https://rdinvesting.com/news/?ticker=SVA.V
Canopy Growth Corporation's stock moved 2.33% lower Friday, to close the day at $18.00. The stock recorded a trading volume of 2,872,061 shares, which was below its three months average volume of 4,947,633 shares. In the last year, Canopy Growth Corporation's shares have traded in a range of 6.58 - 21.72. The share price has gained 173.56% from its 52-week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $16.78 is greater than its 200-day moving average of $10.96. Shares of Canopy Growth have gained approximately 96.94 percent year-to-date.
Access RDI's Canopy Growth Corporation Research Report at:
https://rdinvesting.com/news/?ticker=WEED.TO
On Friday, shares in Spectral Medical Inc. recorded a trading volume of 46,397 shares, which was below the three months average volume of 55,288 shares. The stock ended the day 7.58% lower at 0.30. The share price has gained 60.53% from its 52-week low with a 52-week trading range of 0.19 - 0.64.The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $0.36 is below its 200-day moving average of $0.41.Shares of Spectral Medical have gained approximately 10.91 percent year-to-date.
Access RDI's Spectral Medical Inc. Research Report at:
https://rdinvesting.com/news/?ticker=EDT.TO
Knight Therapeutics Inc.'s stock moved 1.80% lower Friday, to close the day at $7.64. The stock recorded a trading volume of 181,611 shares, which was below its three months average volume of 182,393 shares. In the last year, Knight Therapeutics Inc.'s shares have traded in a range of 7.58 - 11.03. The stock is currently trading 30.73% below its 52-week high. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $8.23 is below its 200-day moving average of $9.04. Shares of the company are trading at a Price to Earnings ratio of 53.80. Shares of Knight Therapeutics have fallen approximately 28.86 percent year-to-date.
Access RDI's Knight Therapeutics Inc. Research Report at:
https://rdinvesting.com/news/?ticker=GUD.TO
On Friday, shares in Sernova Corp. recorded a trading volume of 281,340 shares, which was above the three months average volume of 129,231 shares. The stock ended the day 4.00% higher at 0.26. The share price has gained 85.71% from its 52-week low with a 52-week trading range of 0.14 - 0.33.The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.24 is greater than its 200-day moving average of $0.22. Shares of Sernova have fallen approximately 13.33 percent year-to-date.
Access RDI's Sernova Corp. Research Report at:
https://rdinvesting.com/news/?ticker=SVA.V
Our Actionable Research on Canopy Growth Corporation (TSX:WEED.TO), Spectral Medical Inc. (TSX:EDT.TO), Knight Therapeutics Inc. (TSX:GUD.TO) and Sernova Corp. (TSXV:SVA.V) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com